Assessing Trace Elements Bioaccumulation in Coastal River Fish and Shellfish: Implications for Human Health and Risk Evaluation.

The presence of heavy metal contaminants in fish and shellfish in aquatic environments poses a risk to human health due to trophic transfer. This study determined the levels of various trace elements (Fe, As, Cr, Zn, Cu, Ni, Pb, and Cd) in the muscles, gills, and liver of hilsa (Tenualosa ilisha) and prawn (Macrobrachium rosenbergii) samples obtained from the Tetulia River, Bangladesh. The results showed that the level of trace elements in different body parts differed significantly (P < 0.05) between species, displayed below recommended threshold levels. The cumulative low to higher hierarchic concentration of the trace elements was as follows: Fe > Zn > Cu > Cr > Ni > Pb > As > Cd. Hilsa had significantly (P < 0.05) higher bioaccumulated trace elements compared to prawn. With the exception of Ni and Cd, the estimated daily intakes (EDI) for both adults and children were below the recommended daily allowance (RDA), which exhibits that other trace elements do not cause harm to human health. Furthermore, the hazard index (HI) and total hazard quotient (THQ) were also found to be within acceptable limits, taking into account the higher vulnerability of children to toxicity compared to adults. Notably, the HI suggested that children were approximately four times more susceptible to both carcinogenic and non-carcinogenic effects compared to adults. Ultimately, the levels of carcinogenic risk were deemed acceptable, despite the estimated values suggesting susceptibility to adverse effects in both adults and children. This study concluded that fish and shellfish may not pose a health risk to consumers, highlighting the importance of further monitoring of trace elements in the catchment area.

Comparison of predicted postoperative forced expiratory volume in the first second (FEV1) using lung perfusion scintigraphy with observed forced expiratory volume in the first second (FEV1) post lung resection.

Lung perfusion scintigraphy is done as a part of preoperative evaluation in lung cancer patients for the prediction of postoperative forced expiratory volume in the first second (FEV1). This study was performed to see the accuracy of prediction of postoperative FEV1 by perfusion scintigraphy for patients undergoing lobectomy/pneumonectomy by comparing it with actual postoperative FEV1 obtained by spirometry 4-6 months after surgery. We retrospectively reviewed 50 surgically resected lung cancer patients who underwent preoperative spirometry, lung perfusion study, and postoperative spirometry. Pearson's correlation coefficient was used to evaluate the relationship between predicted postoperative FEV1 (PPO FEV1) by lung perfusion scintigraphy and postoperative actual FEV1 measured by spirometry. Agreement between the two methods was analyzed with Bland-Altman method. The correlation between the PPO FEV1 and actual postoperative FEV1 was statistically significant (r = 0.847, P = 0.000). The correlation was better for pneumonectomy compared to lobectomy (r = 0.930 [P = 0.000] vs. 0.792 [P = 0.000]). The agreement analysis showed a mean difference of -0.0558 with a standard deviation (SD) of 0.284. The limits of agreement vary over a wide range from --0.625 to 0.513 L (mean ± 2 SD) for the entire group. For pneumonectomy, the mean difference was -0.0121 and SD 0.169 with limits of agreement varying between -0.30 L and 0.30 L. For lobectomy, the mean difference was -0.0826 and SD 0.336 with limits of agreement varying between -0.755 L and 0.590 L. Postoperative FEV1 predicted using lung perfusion scintigraphy shows good correlation with actual postoperative FEV1 and shows reasonably good agreement in patients undergoing pneumonectomy. The limits of agreement appear to be clinically unacceptable in patients undergoing lobectomy, where single-photon emission computed tomography (SPECT) or SPECT/CT techniques may improve prediction.

18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan Finding of Portal Venous Tumor Thrombus in a Case of Primary Gastric Malignancy.

Intraluminal portal venous tumor thrombus is an infrequent association with primary gastric malignancy. Ultrasonography features such as low pulsatile flow within the thrombus, expansion of vein, and enhancement of thrombus are nonspecific findings for diagnosis. 18F-fluorodeoxyglucose positron emission tomography-computed tomography scan can differentiate between the benign and malignant thrombus as well as it helps proper metastatic work up. We report such a case.

Stimulated high serum thyroglobulin with negative whole body imaging do not warrant an aggressive diagnostic and therapeutic approach in differentiated thyroid cancer patients: A follow-up of 5 years or till recurrence.

OBJECTIVE: To study the clinical significance of stimulated high serum thyroglobulin (sTg) and of normal whole body imaging (WBI) in differentiated thyroid cancer (DTC) patients during their first follow-up and in a 5 years follow-up or till recurrence. SUBJECTS AND METHODS: Sixty four DTC patients were retrospectively studied and were divided into two groups. Group 1, of 35 patients with disease free status on their first follow-up and group 2, of 29 patients with high sTg (>2 µg/mL), but with normal WBI, iodine-131 (¹³¹I) findings. Patients were categorized into low, intermediate and high risk patients based on the ¹³¹I WBS findings. Histology, stage and risk-categories of both groups were statistically correlated. Best sTg cut-off for predicting recurrence was generated by receiver operating characteristic (ROC). Odd ratio for sTg trend was also analyzed for risk of recurrence in group 2. Independent t test was used for progression free survival (PFS) comparison of the two groups. RESULTS: No statistical differences were seen in histology, stage and risk category distributions between the groups. Group 2 patients with high sTg (range 2.5-81 µg/L, mean 20.5 µg/L) on their first follow-up had higher risk of recurrence (odd ratio 4.304) but P value was insignificant (P:0.090). Eighty six per cent of group 2 patients showed decreasing trends and in 62% of group 2 patients, high serum sTg fell to normal. Indeed, decreasing trends of sTg reduced the risk of recurrence (odd ratio 1.3939, P:0.79). Analysis by ROC showed that sTg>11 µg/L was the best cut-off in predicting recurrence with sensitivity 100% and specificity 56%. High sTg was not associated with low PFS, (P:0.232), however patients with increasing sTg had significantly shorter PFS (P<0.005). CONCLUSION: High sTg with negative ¹³¹I WBS did not warrant an aggressive DTC disease. These patients in their 5 years or till recurrence follow-up showed downward trends of serum sTg, no higher risk or recurrence and no shorter PFS.